Home › Neurologic Diseases › New York › New York City
Neurologic Diseases clinical trials in New York City, NY
6 studies for Neurologic Diseases are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
RecruitingPhase 2
- Clinical Site, New York
Product Surveillance Registry
RecruitingObservational study
- New York, New York
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
RecruitingPhase 2
- Vima Site #024, New York
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
RecruitingPhase 2
- Clinical Site, New York
Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)
RecruitingObservational study
- Icahn School of Medicine at Mount Sinai, New York
INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study
Recruiting
- Mount Sinai Hospital, New York
About Neurologic Diseases
Your nervous system includes your brain, spinal cord, and nerves. Learn about neurologic diseases, including their symptoms, causes, and treatments.
More about Neurologic Diseases on MedlinePlus
Neurologic Diseases trials in other cities
- Boston, MA10 studies
- Washington, DC8 studies
- Dallas, TX7 studies
- Orlando, FL7 studies
- Miami, FL7 studies
- Philadelphia, PA7 studies
- Houston, TX6 studies
- San Diego, CA6 studies
- St. Louis, MO6 studies
- Chicago, IL6 studies
- Pittsburgh, PA5 studies
- Austin, TX5 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.